1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow AnewPharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma CM082 combined with everolimus, CM082, Everolimus - Renal Cell Cancer Metastatic | Phase 3 | Unknown | AnewPharma | 390 | 2016-12-16 | 2021-02-08 |
Everolimus (1) · vorolanib (1)
China (1)
Jun Guo, MD (1)